Clinical Trials Directory

Trials / Sponsors / DynPort Vaccine Company LLC, A GDIT Company

DynPort Vaccine Company LLC, A GDIT Company

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnPhase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B
Botulism
Phase 32017-10-01
CompletedRandomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and W
Plague Vaccine
Phase 22010-07-01
CompletedDouble Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Botulism Vaccine
Phase 22008-09-01
CompletedTitle: Recombinant Plague Vaccine rF1V in Healthy Volunteers
Healthy Volunteers
Phase 22006-05-01
WithdrawnSafety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vacc
Venezuelan Equine Encephalitis
Phase 12005-07-01
CompletedSafety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V
Pneumonic Plague, Preventive Therapy
Phase 12004-11-01
CompletedStudy to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy
RECOMBINANT BOTULINUM VACCINE A/B
Phase 12004-08-01
CompletedA New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults
Anthrax
Phase 12003-04-01
CompletedStudy of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine
Smallpox
Phase 12002-03-01